phosphorus has been researched along with Hyperuricemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, ZL; Yuan, S; Zhang, ZW | 1 |
| Coresh, J; Fox, CS; Muntner, P; Uribarri, J; Vupputuri, S | 1 |
| Shanholtz, CB; Thompson, JL; Vines, AN | 1 |
| Nabeshima, K; Saito, S; Suzuki, Y | 1 |
1 review(s) available for phosphorus and Hyperuricemia
| Article | Year |
|---|---|
[Acute renal failure in patients with tumor lysis syndrome].
Topics: Acute Kidney Injury; Allopurinol; Diagnosis, Differential; Fluid Therapy; Hemofiltration; Humans; Hyperkalemia; Hyperuricemia; Phosphorus; Renal Dialysis; Tumor Lysis Syndrome; Urate Oxidase | 2004 |
3 other study(ies) available for phosphorus and Hyperuricemia
| Article | Year |
|---|---|
Antacids' side effect hyperuricaemia could be alleviated by long-term aerobic exercise via accelerating ATP turnover rate.
Topics: Adenosine Triphosphate; Adult; Aged; Antacids; Exercise; Female; Humans; Hyperuricemia; Male; Middle Aged; Phosphorus; Steroids; Triglycerides; Uric Acid | 2018 |
Metabolic abnormalities are present in adults with elevated serum cystatin C.
Topics: Adult; Age Factors; C-Reactive Protein; Cystatin C; Female; Fibrinogen; Glomerular Filtration Rate; Hemoglobins; Homocysteine; Humans; Hyperuricemia; Kidney Diseases; Kidney Failure, Chronic; Male; Nutrition Surveys; Phosphorus; Prevalence; Reference Values; United States | 2009 |
Fixed-dose rasburicase 6 mg for hyperuricemia and tumor lysis syndrome in high-risk cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gout Suppressants; Hematologic Neoplasms; Humans; Hyperuricemia; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Phosphorus; Practice Guidelines as Topic; Retrospective Studies; Risk Factors; Treatment Outcome; Tumor Lysis Syndrome; Urate Oxidase; Uric Acid | 2010 |